• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For October 27, 2023

    10/27/23 4:33:22 AM ET
    $ABBV
    $ABR
    $AER
    $AN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate
    Get the next $ABBV alert in real time by email

    Companies Reporting Before The Bell

    • Sanofi (NASDAQ:SNY) is projected to report quarterly earnings at $2.26 per share on revenue of $12.56 billion.

    • Equinor (NYSE:EQNR) is estimated to report earnings for its third quarter.

    • Standard Motor Products (NYSE:SMP) is estimated to report quarterly earnings at $0.98 per share on revenue of $391.23 million.

    • Piper Sandler (NYSE:PIPR) is expected to report quarterly earnings at $1.58 per share on revenue of $298.82 million.

    • Civista Bancshares (NASDAQ:CIVB) is estimated to report quarterly earnings at $0.61 per share on revenue of $40.88 million.

    • Dana (NYSE:DAN) is likely to report quarterly earnings at $0.13 per share on revenue of $2.69 billion.

    • T. Rowe Price Gr (NASDAQ:TROW) is expected to report quarterly earnings at $1.78 per share on revenue of $1.62 billion.

    • AbbVie (NYSE:ABBV) is estimated to report quarterly earnings at $2.70 per share on revenue of $12.92 billion.

    • First Hawaiian (NASDAQ:FHB) is projected to report quarterly earnings at $0.43 per share on revenue of $199.90 million.

    • Fomento Economico (NYSE:FMX) is estimated to report quarterly earnings at $1.40 per share on revenue of $11.67 billion.

    • Gentex (NASDAQ:GNTX) is expected to report quarterly earnings at $0.44 per share on revenue of $566.22 million.

    • Imperial Oil (AMEX:IMO) is expected to report quarterly earnings at $1.91 per share on revenue of $13.29 billion.

    • WisdomTree (NYSE:WT) is likely to report quarterly earnings at $0.10 per share on revenue of $88.63 million.

    • Saia (NASDAQ:SAIA) is estimated to report quarterly earnings at $3.62 per share on revenue of $745.98 million.

    • AerCap Holdings (NYSE:AER) is estimated to report quarterly earnings at $2.73 per share on revenue of $1.89 billion.

    • Arbor Realty Trust (NYSE:ABR) is likely to report quarterly earnings at $0.45 per share on revenue of $99.96 million.

    • LyondellBasell Industries (NYSE:LYB) is estimated to report quarterly earnings at $2.02 per share on revenue of $10.10 billion.

    • Exxon Mobil (NYSE:XOM) is projected to report quarterly earnings at $2.24 per share on revenue of $83.76 billion.

    • Barnes Gr (NYSE:B) is projected to report quarterly earnings at $0.48 per share on revenue of $356.50 million.

    • Chevron (NYSE:CVX) is likely to report quarterly earnings at $3.33 per share on revenue of $47.79 billion.

    • Fortis (NYSE:FTS) is likely to report quarterly earnings at $0.81 per share on revenue of $2.91 billion.

    • Carter's (NYSE:CRI) is likely to report quarterly earnings at $1.54 per share on revenue of $786.35 million.

    • Xcel Energy (NASDAQ:XEL) is likely to report quarterly earnings at $1.27 per share on revenue of $4.00 billion.

    • Phillips 66 (NYSE:PSX) is projected to report quarterly earnings at $4.76 per share on revenue of $38.96 billion.

    • Charter Communications (NASDAQ:CHTR) is expected to report quarterly earnings at $7.94 per share on revenue of $13.63 billion.

    • CBRE Group (NYSE:CBRE) is likely to report quarterly earnings at $0.67 per share on revenue of $7.42 billion.

    • ArcBest (NASDAQ:ARCB) is likely to report quarterly earnings at $1.50 per share on revenue of $1.13 billion.

    • Stanley Black & Decker (NYSE:SWK) is likely to report quarterly earnings at $0.83 per share on revenue of $3.97 billion.

    • Portland Gen Electric (NYSE:POR) is expected to report quarterly earnings at $0.54 per share on revenue of $749.17 million.

    • NatWest Group (NYSE:NWG) is likely to report earnings for its third quarter.

    • Lincoln Electric Holdings (NASDAQ:LECO) is projected to report quarterly earnings at $2.25 per share on revenue of $1.04 billion.

    • Stellar Bancorp (NYSE:STEL) is estimated to report quarterly earnings at $0.57 per share on revenue of $109.35 million.

    • AutoNation (NYSE:AN) is projected to report quarterly earnings at $5.49 per share on revenue of $6.72 billion.

    • Colgate-Palmolive (NYSE:CL) is expected to report quarterly earnings at $0.80 per share on revenue of $4.82 billion.

    • nVent Electric (NYSE:NVT) is likely to report quarterly earnings at $0.73 per share on revenue of $881.14 million.

    • Cumulus Media (NASDAQ:CMLS) is estimated to report quarterly loss at $0.19 per share on revenue of $207.47 million.

    • Oil States International (NYSE:OIS) is estimated to report quarterly earnings at $0.04 per share on revenue of $189.85 million.

    • Gorman-Rupp (NYSE:GRC) is expected to report quarterly earnings at $0.32 per share on revenue of $163.79 million.

    • Balchem (NASDAQ:BCPC) is likely to report quarterly earnings at $0.97 per share on revenue of $237.08 million.

    • Alliance Res Partners (NASDAQ:ARLP) is likely to report quarterly earnings at $1.28 per share on revenue of $667.56 million.

    • Virtus Inv (NASDAQ:VRTS) is likely to report quarterly earnings at $6.21 per share on revenue of $200.57 million.

    • Civeo (NYSE:CVEO) is estimated to report quarterly earnings at $0.21 per share on revenue of $166.74 million.

    • Newell Brands (NASDAQ:NWL) is expected to report quarterly earnings at $0.23 per share on revenue of $2.12 billion.

    • Eni (NYSE:E) is likely to report earnings for its third quarter.

    • Booz Allen Hamilton (NYSE:BAH) is projected to report quarterly earnings at $1.33 per share on revenue of $2.61 billion.

    • Aon (NYSE:AON) is estimated to report quarterly earnings at $2.21 per share on revenue of $2.89 billion.

    • PNM Resources (NYSE:PNM) is likely to report quarterly earnings at $1.34 per share on revenue of $651.91 million.

    • Chart Industries (NYSE:GTLS) is estimated to report quarterly earnings at $1.61 per share on revenue of $1.04 billion.

    • Avantor (NYSE:AVTR) is estimated to report quarterly earnings at $0.25 per share on revenue of $1.71 billion.

    Companies Reporting After The Bell

    • Socket Mobile (NASDAQ:SCKT) is projected to report quarterly loss at $0.07 per share on revenue of $5.22 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ABBV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABBV
    $ABR
    $AER
    $AN

    CompanyDatePrice TargetRatingAnalyst
    Aon plc
    $AON
    2/27/2026$397.00Neutral → Outperform
    Mizuho
    AbbVie Inc.
    $ABBV
    2/25/2026$260.00Outperform
    RBC Capital Mkts
    Imperial Oil Limited
    $IMO
    2/23/2026Sector Perform → Underperform
    RBC Capital Mkts
    CBRE Group Inc
    $CBRE
    2/23/2026$185.00Neutral → Buy
    UBS
    AbbVie Inc.
    $ABBV
    2/20/2026$275.00Overweight
    Barclays
    Chevron Corporation
    $CVX
    2/17/2026$205.00Hold → Buy
    Melius
    Xcel Energy Inc.
    $XEL
    2/13/2026$89.00Neutral → Buy
    UBS
    Sanofi
    $SNY
    2/12/2026Buy → Neutral
    BofA Securities
    More analyst ratings

    $ABBV
    $ABR
    $AER
    $AN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T bought $458,000 worth of shares (50,000 units at $9.16) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/23/26 8:53:53 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Summe Gregory L bought $940,000 worth of shares (100,000 units at $9.40) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/12/26 5:24:47 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Knight Lester B bought $1,276,956 worth of Class A Ordinary Stock (4,000 units at $319.24) (SEC Form 4)

    4 - Aon plc (0000315293) (Issuer)

    2/12/26 4:34:45 PM ET
    $AON
    Specialty Insurers
    Finance

    $ABBV
    $ABR
    $AER
    $AN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $ABR
    $AER
    $AN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aon upgraded by Mizuho with a new price target

    Mizuho upgraded Aon from Neutral to Outperform and set a new price target of $397.00

    2/27/26 8:20:07 AM ET
    $AON
    Specialty Insurers
    Finance

    RBC Capital Mkts initiated coverage on AbbVie with a new price target

    RBC Capital Mkts initiated coverage of AbbVie with a rating of Outperform and set a new price target of $260.00

    2/25/26 7:48:26 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Imperial Oil downgraded by RBC Capital Mkts

    RBC Capital Mkts downgraded Imperial Oil from Sector Perform to Underperform

    2/23/26 8:32:07 AM ET
    $IMO
    Integrated oil Companies
    Energy

    $ABBV
    $ABR
    $AER
    $AN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, BOE & CCO Hodari Jamie was granted 10,583 shares, increasing direct ownership by 32% to 43,436 units (SEC Form 4)

    4 - CBRE GROUP, INC. (0001138118) (Issuer)

    2/27/26 6:16:42 PM ET
    $CBRE
    Real Estate
    Finance

    Director Clancy Vincent was granted 6,791 shares, increasing direct ownership by 19% to 41,927 units (SEC Form 4)

    4 - CBRE GROUP, INC. (0001138118) (Issuer)

    2/27/26 6:15:40 PM ET
    $CBRE
    Real Estate
    Finance

    CFO & Chief Investment Officer Giamartino Emma E. was granted 10,900 shares, covered exercise/tax liability with 943 shares and sold $1,370,630 worth of shares (9,223 units at $148.61), increasing direct ownership by 0.58% to 126,501 units (SEC Form 4)

    4 - CBRE GROUP, INC. (0001138118) (Issuer)

    2/27/26 6:14:37 PM ET
    $CBRE
    Real Estate
    Finance

    $ABBV
    $ABR
    $AER
    $AN
    SEC Filings

    View All

    CBRE Group Inc filed SEC Form 8-K: Leadership Update

    8-K - CBRE GROUP, INC. (0001138118) (Filer)

    2/27/26 5:17:37 PM ET
    $CBRE
    Real Estate
    Finance

    SEC Form 424B5 filed by NatWest Group plc

    424B5 - NatWest Group plc (0000844150) (Filer)

    2/27/26 4:58:56 PM ET
    $NWG
    Commercial Banks
    Finance

    SEC Form 10-K filed by Chart Industries Inc.

    10-K - CHART INDUSTRIES INC (0000892553) (Filer)

    2/27/26 4:56:34 PM ET
    $GTLS
    Metal Fabrications
    Industrials

    $ABBV
    $ABR
    $AER
    $AN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chart Industries Reports Fourth Quarter and Full Year 2025 Financial Results

    HOUSTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE:GTLS) today reported results for the fourth quarter and full year ended December 31, 2025. Full year 2025 compared to full year 2024: Orders of $5.68 billion increased 13.4%; full year 2025 book-to-bill of 1.33Sales of $4.26 billion increased 2.5%; sales increased 4.1% excluding a large lifecycle project and a large aftermarket equipment sale in 2024, which did not repeat in 2025Reported operating income of $358.4 million (8.4% of sales) or $884.4 million when adjusted for deal related costs and step-up amortization related to the Howden acquisition, resulted in 20.7% adjusted operating income margin, a decrease of 4

    2/27/26 4:30:00 PM ET
    $GTLS
    Metal Fabrications
    Industrials

    FEMSA Announces Date for Shareholders' Meetings and Dividend Payment Proposal

    MONTERREY, Mexico, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. ("FEMSA" or the "Company") (NYSE:FMX, BMV:FEMSAUBD, FEMSAUB)) announced that it will hold its Annual Ordinary Shareholders' Meeting, as well as an Extraordinary Shareholders' Meeting on March 27, 2026, in Monterrey, Nuevo Leon, Mexico (the "Shareholders' Meetings"). The formal notice will be available in the following link in the coming days: https://femsa.gcs-web.com/shareholder-meeting-information. The detailed proposals for each item on the agenda of the Shareholders' Meetings, as well as the persons nominated to serve as members of FEMSA's Board of Directors and its committees, will be avai

    2/27/26 4:27:10 PM ET
    $FMX
    Beverages (Production/Distribution)
    Consumer Staples

    Number of shares and votes in BioArctic AB (publ) as of February 27, 2026

    STOCKHOLM, Feb. 27, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company issued 78,000 Class B shares during February for delivery of shares to participants in the 2019/2028 stock option program resolved at the Annual General Meeting on May 9, 2019. The shares were issued through an exercise of 78,000 stock options of series 2019/2028. As of February 27, 2026, the last trading day of the month, the total number of shares in BioArctic AB amounted to 88,719,485 shares, of which 74,319,489 listed Class B shares and 14,399,996 unlisted Class A shares. The A share has ten votes per share and the B share has one vote per share. The total number of vo

    2/27/26 12:55:00 PM ET
    $B
    Precious Metals
    Basic Materials

    $ABBV
    $ABR
    $AER
    $AN
    Leadership Updates

    Live Leadership Updates

    View All

    Civista Bancshares, Inc. Appoints Veronica Doucette as an Officer of the Holding Company

    SANDUSKY, Ohio, Feb. 26, 2026 /PRNewswire/ -- Civista Bancshares, Inc. announced the appointment of Veronica Doucette as an officer of Civista Bancshares, Inc. Ms. Doucette currently serves as Senior Vice President, Human Resources Officer for Civista Bank and brings extensive leadership experience to her expanded role within the Civista Bancshares organization. Her appointment reflects Civista Bancshares' continued focus on strong leadership and alignment across the company's operating subsidiaries."Veronica has been a valued member of the Civista Bank Executive Team," said Den

    2/26/26 5:00:00 PM ET
    $CIVB
    Major Banks
    Finance

    Proficient Auto Logistics Appoints Rohit Lal to Board of Directors

    JACKSONVILLE, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (NASDAQ:PAL) today announced that the Board of Directors (the "Board") of Proficient Auto Logistics, Inc. (the "Company") appointed Rohit Lal ("Mr. Lal") to serve as a member of the Board. Mr. Lal currently serves as the Executive Vice President of IT Strategy for Saia, Inc (NASDAQ:SAIA) ("Saia"), where he leads IT teams to develop and deliver enterprise-wide solutions from applications to analytics. "Rohit brings significant experience in enterprise technology strategy and digital transformation," said Rick O'Dell, Proficient's Chief Executive Officer. "His expertise will enhance our Board as we continu

    2/26/26 4:30:00 PM ET
    $PAL
    $SAIA
    Transportation Services
    Consumer Discretionary
    Trucking Freight/Courier Services
    Industrials

    Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

    Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. "Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue expanding our capabilities in this important and evolving space," said J.P. Peltier, global co-head of investment banking and capital markets. "I'm honored to step into this new role and excited to work alongside our talented te

    2/25/26 9:00:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $ABBV
    $ABR
    $AER
    $AN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AutoNation Inc.

    SC 13D/A - AUTONATION, INC. (0000350698) (Subject)

    11/27/24 9:30:26 PM ET
    $AN
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by NatWest Group plc

    SC 13D/A - NatWest Group plc (0000844150) (Subject)

    11/25/24 12:16:00 PM ET
    $NWG
    Commercial Banks
    Finance

    SEC Form SC 13G filed by WisdomTree Inc.

    SC 13G - WisdomTree, Inc. (0000880631) (Subject)

    11/21/24 5:28:49 PM ET
    $WT
    Investment Bankers/Brokers/Service
    Finance

    $ABBV
    $ABR
    $AER
    $AN
    Financials

    Live finance-specific insights

    View All

    Chart Industries Reports Fourth Quarter and Full Year 2025 Financial Results

    HOUSTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE:GTLS) today reported results for the fourth quarter and full year ended December 31, 2025. Full year 2025 compared to full year 2024: Orders of $5.68 billion increased 13.4%; full year 2025 book-to-bill of 1.33Sales of $4.26 billion increased 2.5%; sales increased 4.1% excluding a large lifecycle project and a large aftermarket equipment sale in 2024, which did not repeat in 2025Reported operating income of $358.4 million (8.4% of sales) or $884.4 million when adjusted for deal related costs and step-up amortization related to the Howden acquisition, resulted in 20.7% adjusted operating income margin, a decrease of 4

    2/27/26 4:30:00 PM ET
    $GTLS
    Metal Fabrications
    Industrials

    FEMSA Announces Date for Shareholders' Meetings and Dividend Payment Proposal

    MONTERREY, Mexico, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. ("FEMSA" or the "Company") (NYSE:FMX, BMV:FEMSAUBD, FEMSAUB)) announced that it will hold its Annual Ordinary Shareholders' Meeting, as well as an Extraordinary Shareholders' Meeting on March 27, 2026, in Monterrey, Nuevo Leon, Mexico (the "Shareholders' Meetings"). The formal notice will be available in the following link in the coming days: https://femsa.gcs-web.com/shareholder-meeting-information. The detailed proposals for each item on the agenda of the Shareholders' Meetings, as well as the persons nominated to serve as members of FEMSA's Board of Directors and its committees, will be avai

    2/27/26 4:27:10 PM ET
    $FMX
    Beverages (Production/Distribution)
    Consumer Staples

    Arbor Realty Trust Reports Fourth Quarter and Full Year 2025 Results and Declares Dividend of $0.30 per Share

    Fourth Quarter Highlights: GAAP net income of $0.07 per diluted common shareDistributable earnings1 of $0.19, or $0.22 per diluted common share, excluding $5.1 million of net realized losses from the resolution of certain legacy assets previously reserved forDeclares cash dividend on common stock of $0.30 per shareAgency loan originations of $1.63 billionStructured loan originations of $1.10 billion, our strongest quarter in over three yearsIssued $400.0 million of 8.50% senior unsecured notes due 2028Unwound CLO 16 with $482.1 million of outstanding notes generating ~$90 million of liquidityForeclosed on six loans totaling $139.0 million and sold three real estate owned properties totaling

    2/27/26 8:30:00 AM ET
    $ABR
    Real Estate Investment Trusts
    Real Estate

    $ABBV
    $ABR
    $AER
    $AN
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Exxon Mobil Corporation on Jun 20

    Director Dreyfus Maria S. bought $2,000,386 worth of shares (18,310 units at $109.25), increasing direct ownership by 105% to 35,757 units (SEC Form 4) on June 20, 2024. This substantial insider purchase is a significant development for Exxon Mobil Corporation. As we delve into the recent insider activity at Exxon Mobil, we notice a few interesting patterns. Prior to Dreyfus Maria S.'s purchase, we observed that on January 4, 2024, Ubben Jeffrey W. granted 2,500 shares, which could signal confidence in the company. On the same day, Powell Dina H. claimed no ownership of stock but was granted 8,000 shares, indicating a new ownership stake. These events suggest a mix of adjustments in holding

    6/20/24 1:39:11 PM ET
    $XOM
    Integrated oil Companies
    Energy